Professor John Kennedy

Vincent's, which was the first of those.

And

It's a really important roadmap.

You may not deliver everything.

It may not be perfect, but it says this is what we need to focus on for the next 10 years.

And I think that it's taken very seriously by the substantial number of people that contribute to it.

And I think it's a very good thing that we do that.

And we will be doing it again.

I understand that plan to do it again.

And here we are.

There was, I mean, a document like that is very long and it goes through a very large number of things, starting with prevention, early detection, access, treatment, follow up, survivorship, clinical trials.

Some of the recommendations have been well implemented and they're ongoing.

Some have not been implemented because COVID interrupted, for instance.

And others simply have not made it to the top of the pile of things to be done.

I think one of the things that I would comment on, and this was recently brought out at the – I think the PAC by one of the CEOs of one of the Dublin hospitals, is that the notion that every year there's an annual funding –

discussion for cancer care, but other cares as well, obviously in major hospitals, is an issue.

We need to be thinking about multi-year funding to get programmes delivered rather than having stop-start funding.

That is very difficult to plan, highly complex, multidisciplinary care.

It's very difficult and we need to think about that.

How do we address that?